U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06248957) titled 'SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION' on Jan. 31.
Brief Summary: The aim of the SAID study is to create a national resource in Sweden to enable comprehensive immunological analyses of an extremely complex and clinically challenging group of individuals with variable forms of immune system dysregulation. We hope to establish a biobank of primarily blood and fecal samples from children and adults, with confirmed or suspected immune dysregulation, as well as age- and sex- matched healthy controls, for comparisons of immune cell/mediator alongside various clinical presentations of these immunological diseases as well as microbi...